Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0000947871-25-000799 0002083167 XXXXXXXX LIVE 2 Common Stock, $0.001 par value per share 04/02/2026 false 0001829280 34630N106 Forian Inc. 41 University Drive Suite 400 Newtown PA 18940 Creighton Condon (212) 848-7628 599 Lexington Ave. New York NY 10022 0002083167 N 2025 Acquisition Company, LLC b PF N DE 0.00 0.00 0.00 0.00 0.00 N 0.0 CO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Bravo Merger Sub, Inc. b PF N MD 0.00 0.00 0.00 0.00 0.00 N 0.0 CO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. 0001847923 N Max C. Wygod b PF N X1 1328927.00 2530475.00 1328927.00 2530475.00 3859402.00 N 12.4 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Emily Bushnell b PF N X1 901224.00 2530475.00 901224.00 2530475.00 3431699.00 N 11 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ADMINISTRATIVE TRUST U/ WYGOD FAMILY RV b OO N X1 0.00 1040899.00 0.00 1040899.00 1040899.00 N 3.3 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Anthony Vuolo b PF N X1 4015795.00 0.00 4015795.00 0.00 4015795.00 Y 12.9 IN ITEMS 7, 9 Includes (i) 3,645,399 shares held by the Max Wygod Family Dynasty Trust of which Mr. Vuolo is trustee and has sole investment and dispositive power; Mr. Vuolo disclaims beneficial ownership of these shares; and 370,396 shares held directly by Mr. Vuolo. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y MAX WYGOD & EMILY W BUSHNELL CO-TTEE b OO N X1 0.00 1489576.00 0.00 1489576.00 1489576.00 N 4.8 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. 0001911170 N MAX WYGOD FAMILY DYNASTY TRUST b OO N X1 0.00 3645399.00 0.00 3645399.00 3645399.00 N 11.7 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. 0000926475 N FEINBERG LARRY N b PF N X1 281380.00 1084727.00 281380.00 1084727.00 1366107.00 N 4.4 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ORACLE PARTNERS, L.P. b PF N DE 0.00 935598.00 0.00 935598.00 935598.00 N 3 PN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ORACLE INSTITUTIONAL PARTNERS, L.P. b PF N DE 0.00 113929.00 0.00 113929.00 113929.00 N 0.4 PN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Todd Dublin b PF N X1 11000.00 0.00 11000.00 0.00 11000.00 N 0 IN The shares reported herein are held in the Reporting Person's personal IRA. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ORACLE INVESTMENT MANAGEMENT, INC. EMPLOYEES' RETIREMENT PLAN b PF N CT 0.00 28000.00 0.00 28000.00 28000.00 N 0.1 EP OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y THE FEINBERG FAMILY FOUNDATION b PF N CT 0.00 7200.00 0.00 7200.00 7200.00 N 0.0 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ORACLE ASSOCIATES, LLC b PF N DE 0.00 1049527.00 0.00 1049527.00 1049527.00 N 3.4 HC OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ORACLE INVESTMENT MANAGEMENT, INC. b PF N DE 0.00 1077527.00 0.00 1077527.00 1077527.00 N 3.5 CO IA ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y FEINBERG FAMILY TRUST b PF N X1 0.00 748865.00 0.00 748865.00 748865.00 N 2.4 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ADAM USDAN b PF N X1 0.00 748865.00 0.00 748865.00 748865.00 Y 2.4 IN ITEMS 8, 10, 11 Mr. Usdan disclaims beneficial ownership of these shares. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. 0001847745 N Adam H. Dublin b SC N X1 2505533.00 0.00 2505533.00 0.00 2505533.00 N 8 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y ADAM H. DUBLIN 2019 FAMILY TRUST b PF N X1 0.00 1831526.00 0.00 1831526.00 1831526.00 N 5.9 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Phyllis Dublin b PF N X1 0.00 1831526.00 0.00 1831526.00 1831526.00 Y 5.9 IN ITEM 8, 10, 11 Ms. Dublin disclaims beneficial ownership of these shares. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. 0001848884 N Edward Francis Spaniel, Jr. b PF N X1 688965.00 1831526.00 688965.00 1831526.00 2520491.00 Y 8.1 IN ITEMS 8, 10 Mr. Spaniel disclaims beneficial ownership of these shares. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Peter Dublin b SC N X1 23757.00 0.00 23757.00 0.00 23757.00 N 0.1 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Carl Berg b PF N X1 597000.00 943878.00 597000.00 943878.00 1540878.00 N 4.9 IN ITEMS 8, 10, 11 Includes (i) 525,000 shares held jointly by Mr. Berg and his spouse, Rachel Berg, (ii) 237,578 shares held by Rachel Berg GST Exempt 2012 Trust, of which Mr. Berg is trustee, (iii) 52,000 shares held by Rachel Berg, over which Mr. Berg has investment authority, (iv) 32,300 shares held by Eric Berg, over which Mr. Berg has investment authority, (v) 30,300 shares held by Adam Berg, over which Mr. Berg has investment authority, (vi) 36,700 shares held by Emma Berg, over which Mr. Berg has investment authority, and (vii) 30,000 shares held by Alexander Berg, over which Mr. Berg has investment authority. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y MARBLE LANE PARTNERS I, LLC b PF N DE 1472984.00 0.00 1472984.00 0.00 1472984.00 N 4.7 PN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Michael Sawyer b SC PF N X1 717699.00 717699.00 717699.00 717699.00 717699.00 N 2.3 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y NELL AND JANE CAMERON 2006 TRUST b PF N CT 618908.00 618908.00 618908.00 618908.00 618908.00 N 2.0 HC ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. 0001847744 N Shahir Kassam-Adams b PF N X1 202434.00 0.00 202434.00 0.00 202434.00 N 0.6 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y 360 Ventures, LLC b PF N VA 202434.00 0.00 202434.00 0.00 202434.00 N 0.6 HC ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Charles Mele b OO N X1 103911.00 0.00 103911.00 0.00 103911.00 N 0.3 IN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Michael Glick b PF N X1 0.00 80154.00 0.00 80154.00 80154.00 N 0.3 IN ITEMS 8, 10 Includes 80,154.00 shares held by Mr. Glick in joint tenancy with his spouse, Sharon Glick. ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Milk Town Partners LLC b PF N X1 237578.00 0.00 237578.00 0.00 237578.00 N 0.8 PN ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Y Thomas J. Coleman Revocable Trust b PF N X1 670900.00 0.00 670900.00 0.00 670900.00 N 2.1 OO ITEM 13 Calculated based on 31,208,751 shares of common stock of the Issuer outstanding as of March 25, 2026, as reported on the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Common Stock, $0.001 par value per share Forian Inc. 41 University Drive Suite 400 Newtown PA 18940 This Amendment No. 2 to Schedule 13D ("Amendment No. 2") relates to shares of Common Stock, par value $0.001 per share ("Shares") of Forian Inc., a Delaware corporation (the "Issuer"). This Amendment No. 2 is being jointly filed on behalf of the following persons (collectively, the "Reporting Persons"): (i) 2025 Acquisition Company, LLC (the "SPV"), a Delaware limited liability company, (ii) Max. C. Wygod, an individual, (iii) Emily Bushnell, an individual, (iv) the ADMINISTRATIVE TRUST U/ WYGOD FAMILY RV (the "Administrative Trust"), (v) the MAX WYGOD & EMILY W BUSHNELL CO-TTEE WYGOD FAMILY REV LT U/T/A (vi) Anthony Vuolo, an individual, (vii) the MAX WYGOD FAMILY DYNASTY TRUST, (viii) ORACLE PARTNERS, L.P., a Delaware limited partnership ("Partners"), (ix) ORACLE INSTITUTIONAL PARTNERS, L.P., a Delaware limited partnership ("Institutional Partners"), (x) ORACLE INVESTMENT MANAGEMENT, INC. EMPLOYEES' RETIREMENT PLAN, a employee benefit plan organized in Connecticut (the "Retirement Plan"), (xi) the FEINBERG FAMILY FOUNDATION, a foundation organized in Connecticut (the "Foundation"), (xii) ORACLE ASSOCIATES, LLC, a Delaware limited liability company ("Oracle Associates"), (xiii) ORACLE INVESTMENT MANAGEMENT, INC., a Delaware corporation(the "Investment Manager"), (xiv) Larry N. Feinberg, an individual, (xv) the FEINBERG FAMILY TRUST, a Connecticut Trust, (xvi) Adam Usdan, solely as trustee of the FEINBERG FAMILY TRUST, (xvii) Adam H. Dublin, an individual, (xviii) the ADAM H. DUBLIN 2019 FAMILY TRUST, (xix) Phyllis Dublin, solely as co-trustee of the ADAM H. DUBLIN 2019 FAMILY TRUST, (xx) Edward Francis Spaniel, Jr., an individual and co-trustee of the ADAM H. DUBLIN 2019 FAMILY TRUST, (xxi) Carl Berg, an individual on behalf of Alexander Ryan Berg, Adam Charles Berg, Eric William Berg, and Emma RoseBerg, (xxii) MARBLE LANE PARTNERS I, LLC, (xxiii) Michael Sawyer, an individual, (xxiv) NELL AND JANE CAMERON 2006 TRUST, (xxv) Keri Cameron, solely on behalf of the NELL AND JANE CAMERON 2006 TRUST, (xxvi) Shahir Kassam-Adams, an individual, (xxvii) 360 Ventures, LLC, a Virginia limited liability company, (xxviii) Charles Mele, an individual, (xxix) Michael and Sharon Glick, as individuals holding shares in joint tenancy, (xxx) BRAVO MERGER SUB, INC., a Maryland corporation ("Merger Sub"), (xxxi) the THOMAS J. COLEMAN REVOCABLE TRUST, a New York Trust, (xxxii) Milk Town Partners LLC, a Connecticut partnership, (xxxiii) Todd Dublin, an individual, and (xxxiv) Peter Dublin, an individual, and amends the Statement on Schedule 13D filed by the Reporting Persons on August 25, 2025 ("Initial Schedule 13D"). Item 2(a) of the Initial Schedule 13D is hereby amended and supplemented by adding the following text: Bravo Merger Sub, Inc., a Maryland corporation, Thomas J. Coleman Revocable Trust, a New York Trust, Milk Town Partners LLC, a Connecticut partnership, Todd Dublin, an individual, and Peter Dublin, an individual. Item 2(b) of the Initial Schedule 13D is hereby amended and supplemented by adding the following text: Bravo Merger Sub, Inc. The principal address for the corporation is Max C. Wygod, c/o A&O Shearman, ATTN: Chris Glenn, 599 Lexington Avenue, New York, NY 10022. Thomas J. Coleman Revocable Trust. The principal address for the trust is c/o Kensico Capital Management 55 Railroad Avenue, 2nd Fl Greenwich, CT 06830. Milk Town Partners LLC. The principal address for the company is c/o Kensico Capital Management 55 Railroad Avenue, 2nd Fl Greenwich, CT 06830. Todd Dublin. Mr. Todd Dublin's address is 1304 South Halliburton Street, Kirksville, MO 63501. Peter Dublin. Mr. Peter Dublin's address is 224 Franklin Avenue, River Forest, IL 60305 Item 2(c) of the Initial Schedule 13D is hereby amended and supplemented by adding the following text: Item 2(b) of this Amendment No. 2 is incorporated herein by reference. None None United States The disclosure in Item 4 of the Existing Schedule 13D is hereby amended and supplemented by adding the following at the end thereof: Amendment No. 1 to the Consortium Agreement On April 2, 2026, the Consortium entered into the Amendment No. 1 (the "Consortium Agreement Amendment") to the Consortium Agreement (as defined in the Initial 13D), which, among other things, (i) clarifies that the Consortium Agreement remains in full force and effect, notwithstanding any terms therein to the contrary, (ii) provides that the Consortium Agreement will terminate upon the closing of the Merger (as defined below) or a valid termination of the Merger Agreement (as defined below), (iii) imposes certain restrictions to the transfer of Shares prior to such termination (subject to limited permitted transfers to specified transferees who agree to be bound), and (iv) requires each Consortium Member to contribute its Shares to Parent prior to the commencement of the Offer. Merger Agreement Subsequently, on April 2, 2026, the SPV, Bravo Merger Sub, Inc., a Maryland corporation and wholly-owned subsidiary of the SPV ("Merger Sub") and Forian entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"). Pursuant to the Merger Agreement, among other things, and subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into the Company (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, collectively, the "Transactions"), and the separate corporate existence of Merger Sub will thereupon cease, and the Company will continue as the surviving corporation and a wholly owned subsidiary of Parent. The Merger will be governed by Section 3-106.1 of the MGCL and will be effected by Merger Sub and Forian without a stockholder vote as soon as practicable following the consummation of the Offer, pursuant to the MGCL. At the effective time of the Merger (the "Effective Time"), each Share issued and outstanding immediately prior to the Effective Time (other than Shares (i) held by Forian and its subsidiaries, (ii) owned by the Buyer Parties, or (iii) owned by any direct or indirect wholly owned subsidiary of the Buyer Parties as of immediately prior to the Effective Time, which will be automatically cancelled and extinguished without any conversion thereof or consideration paid therefor), subject to any appraisal rights in accordance with Section 3-202 of the MGCL, will be converted into the right to receive $2.17 in cash per Share, without interest, and subject to deduction for any required tax withholding. Each of the Company, Parent and Merger Sub has made customary representations, warranties and covenants in the Merger Agreement, including relating to (i) the conduct of the Company's business during the interim period, (ii) the efforts of each party to cause the Transactions to be completed and (iii) the preparation and filing of a tender offer statement on Schedule TO and a transaction statement on Schedule 13E-3 by Parent, Merger Sub and the Company and a Schedule 14D-9 by the Company in connection with the Transactions. Completion of the Merger is subject to certain closing conditions, including, but not limited to, (i) that the number of Shares validly tendered and not validly withdrawn, together with the number of Shares then owned beneficially by Parent and Merger Sub (together with their wholly owned subsidiaries), equals at least one share more than fifty percent (50%) of all Shares outstanding as of the consummation of the Offer, (ii) the truth and accuracy of certain representations and warranties of Forian as set forth in the Merger Agreement as of the date of the Merger Agreement and as of the expiration date of the Offer (the "Expiration Date") as if made on and as of each such date (as may be subject to materiality, de minimis or other qualifiers), (iii) Forian having performed and complied in all material respects with the covenants, obligations and conditions of the Merger Agreement required to be performed and complied with by Forian at or prior to the Expiration Date, (iv) the non-occurrence of a Company Material Adverse Effect (as defined in the Merger Agreement) on or after the date of the Merger Agreement that is continuing, (v) the non-termination of the Merger Agreement, and (vii) the non-issuance of any judgment, temporary restraining order, preliminary or permanent injunction, or other order from any governmental body of competent jurisdiction preventing the consummation of the Offer or the Merger. Equity Commitment Letter In connection with the Transactions, one of the members of the Consortium, Max Wygod & Emily W Bushnell Co-TTEE Wygod Family Rev LT U/T/A (the "Sponsor"), provided an equity commitment letter dated April 2, 2026 (the "Equity Commitment Letter"), pursuant to which it committed to provide Parent, on the terms and subject to the conditions set forth therein, an aggregate equity commitment of up to $5,500,000 (or such lesser amount required for Merger Sub to fund the purchase, directly or indirectly, of the securities of Parent) to fund the Closing Payments (as defined in the Equity Commitment Letter) under the Merger Agreement (the "Commitment"). The Commitment is available solely to consummate the Transactions and is fundable at or prior to the consummation of the Merger, subject to, among other things, the execution of the Merger Agreement, and the satisfaction or waiver of the conditions of the Merger Agreement. The Equity Commitment Letter also permits allocation of all or a portion of the Commitment to affiliated entities, includes customary non-recourse provisions in favor of non-parties, provides that the Company is an express third-party beneficiary solely entitled to seek specific performance to cause funding of the Commitment, and terminates upon the earliest of the consummation of the Merger, valid termination of the Merger Agreement, or full funding of the Commitment. The foregoing descriptions of the Consortium Agreement Amendment, the Merger Agreement and the Equity Commitment Letter do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, which are filed herewith as Exhibits 99.18, 99.19, 99.20, respectively, and are incorporated herein by reference. Item 5(a) of the Initial 13D is hereby amended and supplemented by adding the following text: The information set forth in rows 11 and 13 of the cover pages of this Amendment No. 2 is incorporated herein by reference. See rows (7) through (10) of the cover pages to this Amendment No. 2 for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. After obtaining consent from the Special Committee of the Board of Directors of the Company and duly executing the Consortium Agreement as of April 2, 2026, prior to the execution of the Merger Agreement, the following shareholders have been added to the Consortium (as defined in Item 4 of the Initial 13D): Thomas J. Coleman Revocable Trust, Milk Town Partners LLC, Todd Dublin and Peter Dublin (the "New Consortium Members"). All references to the Consortium in this Amendment No. 2 and any future amendments to the Initial 13D shall include these shareholders. Because of the arrangements in the Consortium Agreement (as defined in Item 4 of the Initial 13D), the members of the Consortium (as defined in Item 4 of the Initial 13D) may be deemed to have formed a "group" for purposes of Section 13(d)(3) of the Act. Neither the filing of this Schedule 13D nor any of its contents, however, shall be deemed to constitute an admission by the Reporting Persons that any of them is the beneficial owner of any of the 20,689,142 Shares beneficially owned in the aggregate by the Consortium Members, other than such Shares that each Reporting Person has reported as beneficially owned by the respective Reporting Person in this Amendment No. 2, for purposes of Section 13(d) of the Act or for any other purpose, and such beneficial ownership is expressly disclaimed. Item 5(b) of the Initial 13D is hereby amended and supplemented by adding the following text: Except as set forth in this Amendment No. 2, none of the Reporting Persons beneficially owns, or has acquired or disposed of, any Shares during the last 60 days. To the knowledge of the Reporting Persons, no person other than each of the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, Shares beneficially owned by such Reporting Persons. Not applicable. Item 6 of this Schedule 13D is hereby amended and supplemented by adding the following text: Item 4 references the Consortium Agreement Amendment, the Merger Agreement and the Equity Commitment Letter, the descriptions of each of which are incorporated herein by reference. Copies of the Consortium Agreement Amendment, the Merger Agreement and the Equity Commitment Letter are attached as 99.18, 99.19, 99.20, respectively to this Amendment No. 2, and are incorporated herein by reference. Item 7 of the Initial 13D is hereby amended and supplemented by the addition of the following Exhibits: Exhibit 99.4* - Power of Attorney for Adam H. Dublin, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.4 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.5* - Power of Attorney for Adam Usdan, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.5 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.6* - Power of Attorney for Anthony Vuolo, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.6 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.7* - Power of Attorney for Carl Berg, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.7 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.8* - Power of Attorney for Charles Mele, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.8 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.9* - Power of Attorney for Edward Francis Spaniel Jr., dated as of October 2, 2025 (incorporated by reference to Exhibit 99.9 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.10* - Power of Attorney for Keri Cameron, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.10 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.11* - Power of Attorney for Larry Feinberg, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.11 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.12* - Power of Attorney for Marble Lane Partners I, LLC, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.12 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.13* - Power of Attorney for Michael Glick, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.13 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.14* - Power of Attorney for Michael Sawyer, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.14 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.15* - Power of Attorney for Phyllis Dublin, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.15 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.16* - Power of Attorney for Adam Kassam-Adams, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.16 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.17* - Power of Attorney for Emily Bushnell, dated as of October 2, 2025 (incorporated by reference to Exhibit 99.17 to the Amendment No. 1 to the Schedule 13D filed by the Reporting Persons with the SEC on October 2, 2025). sec.gov/Archives/edgar/data/1829280/000094787125000884/xslSCHEDULE_13D_X01/primary_doc.xml Exhibit 99.18 - Amendment No. 1 to the Consortium Agreement, dated April 2, 2026, by and among Mr. Max Wygod and the Consortium Members Exhibit 99.19* - Agreement and Plan of Merger, dated April 2, 2026, by and among the SPV, Merger Sub and the Issuer (incorporated by reference to Exhibit 2.1 to the Issuer's Current Report on Form 8-K, filed April 3, 2026). Exhibit 99.20 - Equity Commitment Letter, dated April 2, 2026, by and between the SPV and the Sponsor. Exhibit 99.21* - Press Release, dated April 2, 2026 (incorporated by reference to Exhibit 99.1 to the Issuer's Current Report on Form 8-K filed, filed April 3, 2026). Exhibit 99.22 - Power of Attorney for Peter Dublin, dated April 2, 2026. Exhibit 99.23 - Power of Attorney for Todd Dublin, dated April 2, 2026. Exhibit 99.24 - Power of Attorney for Thomas J. Coleman, dated April 2, 2026. *Previously filed. 2025 Acquisition Company, LLC /s/ Max C. Wygod Max C. Wygod 04/06/2026 Bravo Merger Sub, Inc. /s/ Max C. Wygod Max C. Wygod 04/06/2026 Max C. Wygod /s/ Max C. Wygod Max C. Wygod 04/06/2026 Emily Bushnell /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Emily Bushnell 04/06/2026 ADMINISTRATIVE TRUST U/ WYGOD FAMILY RV /s/ Max C. Wygod Max C. Wygod, Co-Trustee 04/06/2026 /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Emily Bushnell, Co-Trustee 04/06/2026 Anthony Vuolo /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Anthony Vuolo 04/06/2026 MAX WYGOD & EMILY W BUSHNELL CO-TTEE /s/ Max C. Wygod Max C. Wygod, Co-Trustee 04/06/2026 /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Emily Bushnell, Co-Trustee 04/06/2026 MAX WYGOD FAMILY DYNASTY TRUST /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Anthony Vuolo, Trustee 04/06/2026 FEINBERG LARRY N /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg 04/06/2026 ORACLE PARTNERS, L.P. /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg, Managing Member 04/06/2026 ORACLE INSTITUTIONAL PARTNERS, L.P. /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg, Managing Member 04/06/2026 Todd Dublin /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Todd Dublin 04/06/2026 ORACLE INVESTMENT MANAGEMENT, INC. EMPLOYEES' RETIREMENT PLAN /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg, Trustee 04/06/2026 THE FEINBERG FAMILY FOUNDATION /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg, Trustee 04/06/2026 ORACLE ASSOCIATES, LLC /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg, Managing Member 04/06/2026 ORACLE INVESTMENT MANAGEMENT, INC. /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Larry N. Feinberg, President 04/06/2026 FEINBERG FAMILY TRUST /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Adam Usdan, Trustee 04/06/2026 ADAM USDAN /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Adam Usdan 04/06/2026 Adam H. Dublin /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Adam H. Dublin 04/06/2026 ADAM H. DUBLIN 2019 FAMILY TRUST /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Edward F. Spaniel, Jr., Co-Trustee 04/06/2026 /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Phyllis Dublin 04/06/2026 Phyllis Dublin /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Phyllis Dublin 04/06/2026 Edward Francis Spaniel, Jr. /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Edward F. Spaniel, Jr. 04/06/2026 Peter Dublin /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Peter Dublin 04/06/2026 Carl Berg /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Carl Berg 04/06/2026 MARBLE LANE PARTNERS I, LLC /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for David Mehlman, Managing Member 04/06/2026 Michael Sawyer /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Michael Sawyer 04/06/2026 NELL AND JANE CAMERON 2006 TRUST /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Keri Cameron, Trustee 04/06/2026 Shahir Kassam-Adams /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Shahir Kassam Adams 04/06/2026 360 Ventures, LLC /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Shahir Kassam-Adams, General Manager 04/06/2026 Charles Mele /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Charles Mele 04/06/2026 Michael Glick /s/ Max C. Wygod Max C. Wygod / Attorney-in-fact for Michael Glick 04/06/2026 Milk Town Partners LLC /s/ Max C. Wygod Attorney-in-fact for Thomas J. Coleman 04/06/2026 Thomas J. Coleman Revocable Trust /s/ Max C. Wygod Attorney-in-fact for Thomas J. Coleman 04/06/2026